Biostatistics is involved in all stages of PCCTC clinical trial planning from data collection and analysis to final evaluation. A PCCTC statistician provides crucial input on the design and analysis of clinical trials, randomization procedures, and the increasingly more complex task of interpreting results.
Whether data collected in a clinical trial will have an impact on future patient care or not depends entirely on statistical design.
- Disease-specific expertise in multicenter, hypothesis-driven clinical trials and biomarker validation ensures our studies efficiently measure meaningful prostate cancer endpoints.
- Our statistician works directly with the Clinical Data Management team to optimize a study-specific statistical analysis plans (SAP) to generate quality, informative data and meet critical study milestones.
- PCCTC investigators are at the forefront of novel trial design and have been instrumental in national efforts around prostate cancer endpoints.